AzTrials
AzTrials

Pain DetectionNCT00447824

Pain Detection and Interception in Neonates

A study testing Introduction of better conditions during blood sampling in people with Pain Detection and Pain Intervention, run by Sorlandet Hospital HF at 1 site in Norway.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Hypothesis: 1. May the introduction of NIDCAP during blood sample reduced pain in neonates during blood sample 2. Compare the effect of venous and capillary blood sample method Read more about this study

Who is it for?
Ages 31 to 36 weeksHealthy volunteers can take part
Conditions the study is for
Pain Detection, Pain Intervention
What is being tested?
Introduction of better conditions during blood sampling
Type of treatment
Surgery or procedure
How many people
160 participants
Where
1 siteNorway
Study dates
Mar 2007to Nov 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 31 to 36 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Born gestation age 31-36

Who cannot join

  • Infection, respiratory distress

Trial locations and contacts

1 site in 1 country.

Knut G Hernes, Dr contact

+(47) 957 99999

drhernes@gmail.com

Norway1 site, 1 recruiting
  • Sorlandet Hospital SSHF

    Kristiansand, Vest Agder, 4600

    Liv Normann

    Randi S Dahl

    Recruiting

Other trials in Norway

About this study

Official title: Pain Detection and Interception in Neonates During Blood Sampling

Hypothesis:

  1. May the introduction of NIDCAP during blood sample reduced pain in neonates during blood sample
  2. Compare the effect of venous and capillary blood sample method
Read the detailed description

introducing the: Newborn Individualized Developmental Care and Assessment Program

Being tested
Introduction of better conditions during blood sampling
Keywords
Pain, Neonates, NIDCAP, Venous, Capillary
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Introduction of better conditions during blood samplingProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. value of Premature Infant Pain Profile

  2. Heart rate

  3. Saturation

  4. Skin conductance changes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2007 (estimated)
  2. Study startMar 2007
  3. Study completionNov 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Enrolment
160 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00447824
Sponsor's protocol ID
S-06471a
Status last verified
Mar 2007
First submitted
13 Mar 2007
Last updated
15 Mar 2007
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Introduction of better conditions during blood sampling in people with Pain Detection and Pain Intervention, run by Sorlandet Hospital HF at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Mar 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Knut G Hernes, Dr (+(47) 957 99999, drhernes@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

value of Premature Infant Pain Profile. The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2007.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in